公众号 / 文章呼吸衰竭与机械通气重症综合管理与镇静镇痛

线粒体动力学失衡与新型冠状病毒感染相关急性呼吸窘迫综合征关系的研究进展

[Research progress on the relationship between mitochondrial dynamics imbalance and novel coronavirus infection-related acute respiratory distress syndrome].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论综述指出缺氧与病毒蛋白致线粒体分裂/融合失衡,参与新型冠状病毒感染相关ARDS肺及多器官损伤,现有治疗有限,调控线粒体动力学为潜在方向。

本文为综述,总结线粒体动力学失衡在新型冠状病毒感染相关急性呼吸窘迫综合征(ARDS)中的作用。严重肺炎常并发ARDS,病死率高,病理为弥漫性肺泡损伤、肺水肿和低氧血症。缺氧和病毒感染下线粒体形态功能异常,通过分裂融合维持稳态;ARDS中缺氧致动力相关蛋白1(Drp1)磷酸化,触发线粒体过度分裂并损伤肺泡上皮屏障,动物实验显示抑制该过程可减轻肺损伤。病毒感染与缺氧破坏线粒体平衡,致分裂和自噬异常,促进氧化应激和线粒体DNA释放,激活炎症小体,诱导低氧诱导因子-1α表达,加重感染、炎症和凝血反应,导致多器官损伤。机械通气和糖皮质激素是常用治疗,肺保护性通气策略可减少不良影响,糖皮质激素可多途径调节线粒体功能和免疫反应。现有治疗有局限,未来需深入研究线粒体功能障碍机制并开发新疗法和调控策略。

要点

  • ARDS中缺氧致Drp1磷酸化,触发线粒体过度分裂并损伤肺泡上皮屏障。
  • 动物实验显示抑制线粒体过度分裂过程可减轻肺损伤,为潜在治疗方向。
  • 病毒感染与缺氧致线粒体分裂和自噬异常,促进氧化应激和mtDNA释放,激活炎症小体,诱导HIF-1α表达。
  • 机械通气可能致肺和膈肌损伤及线粒体动力学改变,肺保护性通气策略可减少不良影响。
  • 糖皮质激素可通过多途径调节线粒体功能和免疫反应,改善患者病情。

适用人群与场景

  • 新型冠状病毒感染所致严重肺炎并发急性呼吸窘迫综合征(ARDS)的患者。

处置流程与药物剂量

  • 机械通气是新型冠状病毒感染相关ARDS常用治疗,可能致肺和膈肌损伤及线粒体动力学改变,肺保护性通气策略可减少不良影响。
  • 糖皮质激素是新型冠状病毒感染相关ARDS常用治疗,可通过多途径调节线粒体功能和免疫反应,改善患者病情。

研究设计与关键结果

  • 综述汇总:ARDS以弥漫性肺泡损伤、肺水肿和低氧血症为特征,新型冠状病毒感染相关ARDS病理与典型ARDS相似但更严重。
  • 缺氧致Drp1磷酸化,触发线粒体过度分裂并损伤肺泡上皮屏障;动物实验显示抑制该过程可减轻肺损伤。
  • 病毒感染与缺氧破坏线粒体平衡,致分裂和自噬异常,促进氧化应激和mtDNA释放,激活炎症小体,诱导HIF-1α表达,加重感染、炎症和凝血反应,导致多器官损伤。
  • 机械通气可能致肺和膈肌损伤及线粒体动力学改变,肺保护性通气策略可减少不良影响;糖皮质激素可多途径调节线粒体功能和免疫反应,改善病情。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,明确新型冠状病毒感染相关ARDS中线粒体动力学失衡的病理生理机制并探索调控线粒体动力学平衡的有效策略,可为该病患者提供新的治疗靶点和方法。
  • 现有治疗有局限,未来研究需深入研究线粒体功能障碍机制、开发新疗法和调控策略以提高治疗效果。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Patients with severe pneumonia caused by novel coronavirus infection are often complicated with acute respiratory distress syndrome (ARDS), which has a high mortality. ARDS is characterized by diffuse alveolar damage, pulmonary edema, and hypoxemia. Mitochondria are prone to morphological and functional abnormalities under hypoxia and viral infection, which can lead to cell apoptosis and damage, severely impacting the disease progression. Mitochondria maintain homeostasis through fission and fusion. In ARDS, hypoxia leads to the phosphorylation of dynamin-related protein 1 (Drp1), triggering excessive mitochondrial fission and damaging the alveolar epithelial barrier. Animal experiments have shown that inhibiting this process can alleviate lung injury, providing a potential direction for treatment. The pathology of novel coronavirus infection-related ARDS is similar to that of typical ARDS but more severe. Viral infection and hypoxia disrupt the mitochondrial balance, causing fission and autophagy abnormalities, promoting oxidative stress and mitochondrial DNA (mtDNA) release, activating inflammasomes, inducing the expression of hypoxia-inducible factor-1α (HIF-1α), exacerbating viral infection, inflammation, and coagulation reactions, and resulting in multiple organ damage. Mechanical ventilation and glucocorticoids are commonly used in the treatment of novel coronavirus infection-related ARDS. Mechanical ventilation is likely to cause lung and diaphragm injuries and changes in mitochondrial dynamics, while the lung protective ventilation strategy can reduce the adverse effects. Glucocorticoids can regulate mitochondrial function and immune response and improve the patient's condition through multiple pathways. The mitochondrial dynamics imbalance in novel coronavirus infection-related ARDS is caused by hypoxia and viral proteins, leading to lung and multiple organ injuries. To clarify the pathophysiological mechanism of mitochondrial dynamics imbalance in novel coronavirus infection-related ARDS and explore effective strategies for regulating mitochondrial dynamics balance to treat this disease, so as to provide new treatment targets and methods for patients with novel coronavirus infection-related ARDS. The existing treatments have limitations. Future research needs to deeply study the mechanism of mitochondrial dysfunction, develop new therapies and regulatory strategies, and improve the treatment effect.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhang Z, Du B, Wu X, et al. [Research progress on the relationship between mitochondrial dynamics imbalance and novel coronavirus infection-related acute respiratory distress syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40202004. doi:10.3760/cma.j.cn121430-20241126-00957

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。